Affiliations

The Prostate Centre at Vancouver General Hospital was sanctioned as Centre for Prostate Research by the Senate of the University of British Columbia. All of the Prostate Centre principal investigators hold their appointment through the university, primarily in the Faculty of Medicine.

In 2001, the Genome British Columbia Microarray Platform was established to accommodate the increased throughput and expertise demand on the Microarray facility by the large-scale projects funded by Genome Canada. This partnership enabled acquisition of additional equipment infrastructure and hiring of qualified personnel in areas that include array design, array production, array experimental procedures (labeling, hybridization and scanning), analysis, bioinformatics, biostatistics, and database production and management. To accommodate the new equipment, the Prostate Centre was also required to renovate space, including upgrades to the ventilation and temperature systems and microenvironment control.

Genome Canada is the primary funding and information resource relating to genomics and proteomics in Canada. Dedicated to developing and implementing a national strategy in genomics and proteomics research for the benefit of all Canadians, it has so far received $700 million from the Government of Canada. Genome Canada has established six Genome Centres across the country (Atlantic, Québec, Ontario, Prairies, Alberta and British Columbia) and has as a main objective to ensure that Canada becomes a world leader in genomics and proteomics research. Together with its six Genome Centres and with other partners, Genome Canada invests and manages large-scale research projects in key selected areas such as agriculture, environment, fisheries, forestry, health and new technology development. Genome Canada also supports research projects aimed at studying and analyzing the ethical, environmental, economic, legal and social issues related to genomics research (GE3LS).